ClinPhone, a leading clinical technology suite, has been granted a Best Technological Development in Clinical Trial Management Systems Award for its drug accountability solution at the inaugural GCPj Awards 2007. The Good Clinical Practice Journal Awards were developed to recognize corporate and individual excellence and celebrate innovation. Bill Byrom, vice president, product management, said: “ClinPhone’s drug accountability solution is now successfully supporting many clinical trials worldwide, enabling better accuracy of records and consolidation of data.”

There is $4 million in new federal funding for drug safety research in Arizona. The C-Path Institute will share the Agency for Healthcare Research and Quality (AHRQ) grant with a body called the Arizona Center for Education and Research on Therapeutics (AzCERT). The news release says the four-year award will enable the AzCERT to expand its programs, designed to prevent drug-drug interactions, especially those affecting women.

Generex Biotechnology Corporation picked some key suppliers. The firm selected PSI-CRO Clinical Research Services (PSI) as the company’s global contract research organization (CRO). Another provider is Nextrials, which will be responsible for providing electronic data capture (EDC), randomization, and data management services. Finally, eResearchTechnology will supply equipment and provide central ECG services for the trial. Anna Gluskin, Generex’s president and chief executive officer, said: “We are pleased at the progress the Company has made in securing quality service providers as we prepare to announce trial site locations and commence enrollment.”

Axiom Real-Time Metrics, a provider of electronic data capture, has won a Companies-to-Watch Award, one of four Canadian awards that make up the 2007 Deloitte Technology Fast 50 Awards. Axiom Real-Time Metrics’ CEO, John L. Schroeter, credits his partner and chief application platform architect, president and CTO Andrew Schachter with the creation of an end-user-focused architecture. Schroeter added: “We have developed sophisticated tools to move clinical research from a laborious and slow paper-based process to a markedly more accurate, efficient and adaptive means.”

IBM introduced a new edition of DB2 Warehouse featuring dynamic warehousing advancements. IBM says the enhancements will provide users with “instant” access to information. Karen Parrish, VP of business intelligence solutions for IBM, said: “The new DB2 Warehouse removes traditional technological barriers and allows customers to deliver real-time insights to every person across an organization for every transaction.” Convergence CT, a company that links patient data and clinical trial planning, has already assessed the new DB2 Warehouse. “We’ve found DB2 Warehouse to be perfect for consolidating information about how cancer and diabetes patients respond to different treatments in healthcare facilities around the world,” said Lambert Onuma, CEO, Convergence CT.

WuXi PharmaTech, a large Chinese contract research organization, announced that its future GLP center in Suzhou started construction on September 29, 2007. The CRO will is building a 267,000 square foot preclinical drug safety evaluation center situated in Wuzhong district. It will provide customers with highly value-added toxicology services. The center is expected to become the largest such drug safety evaluation center in China after its completion in 2009. Ge Li, chairman and chief executive officer of WuXi PharmaTech, said: “The new facility, designed by a renowned US architecture firm and to be managed by [a] board certified toxicologist and other experienced scientists, will enable us to further broaden and expand our service capabilities and capacities to meet our customers’ demands.”

The Clinical Data Interchange Standards Consortium (CDISC) is doing a survey of what technologies are actually used in the industry. Here’s the link.

Have a news release? Send it to .